慢性胃炎伴糜烂怎样治疗

慢性胃炎伴糜烂如何治疗配图，仅供参考

Current mainstream treatment options for CEG include lifestyle guidance,MPAs,PPIs,and other symptomatic treatments. Several studies have demonstrated that geranylgeranyl acetone treatment is more effective than cimetidine for chronic gastritis-associated erosions and petechial hemorrhage. In addition,rebamipide had a stronger suppressing effect on mucosal inflammation and provided greater symptom relief in CEG patients than sucralfate. Furthermore,famotidine is effective in relieving abdominal symptoms in chronic symptomatic gastritis. For H. pylori-associated gastritis,anti-H. pylori therapy is recommended and accepted by physicians. However,a significant number of patients in our study were not treated using anti-H. pylori regimens and H. pylori-positive patients consistently exhibited lower symptom relief rates. Treatment of CEG varies across different centers,which is partially because of a lack of consensus and lack of treatment guidelines. However,high-level evidence evaluating the efficacy of existing treatment regimens is currently limited. In our study,PPIs and MPAs were used by 69.9% and 66.8% of patients,respectively,and 31.6% received combination treatment. Further studies comparing relief of the various symptoms between PPI,MPA,PPI MPA,and PPI MPA PD may provide valuable information for selecting the most appropriate drug regimen. If epigastric pain is the predominant symptom,a MPA PPI may provide a better response than a PPI or MPA alone. If abdominal distension is the predominant symptom,MPA may provide a slightly superior response than PPI; however,combining the two did not offer an additional benefit. Nonetheless,adding a PD to a combination of an MPA and a PPI seemed to provide greater symptom relief. If postprandial fullness,early satiety,or nausea are the most notable symptoms,the use of an MPA may be the optimal choice. When symptoms are predominantly related to acid reflux,a PPI or PPI MPA are more effective. For patients whose predominant complaint is dyspepsia,treatment with an MPA is recommended; adding a PD may provide a better response in some cases. Our results demonstrate that individualized treatment based on symptom profile is crucial for patients with CEG.","department":"